PR Newswire Asia's news > Health Care/Hospital

 < Previous page   |   Detail   |   Print    Next page > 
     
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
2026-05-11T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
RingConn Gen 3 Smart Ring Opens for Pre-Order: Bringing Vascular Insights to Effortless Everyday Wear
2026-05-10T    Computer/Electronics   Consumer Electronics   Health Care/Hospital 
Study pinpoints 45 years as the critical threshold for a significant downturn in male fertility
2026-05-10T    Health Care/Hospital   Medical/Pharmaceuticals   Trade show news 
Emotional burden of infertility can undermine lifestyle choices that may help women conceive
2026-05-10T    Health Care/Hospital   Trade show news 
ACROBiosystems Launches Global License Solution Upgrade for HEK293 Functional Cell Lines, Streamlining Compliance to Accelerate Biopharmaceutical R&D
2026-05-10T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
South and East Asia identified as hotspots of global warming related impacts on male fertility
2026-05-09T    Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
Psychosocial support is vital to help those living with infertility to overcome treatment barriers, including stigmas, myths and taboos about IVF
2026-05-09T    Health Care/Hospital   Medical/Pharmaceuticals 
World's First | Mabwell's 9MW5211 Receives FDA Clearance for Clinical Trial Application
2026-05-09T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
AAVnerGene Announces AAVone®2.1, a Next-Generation Single-Plasmid AAV Production Platform Achieving ~1e16 GC/L and >70% Full Capsids at Harvest
2026-05-08T    Biotechnology   Computer/Electronics   Health Care/Hospital   Medical/Pharmaceuticals 
The sNDA for Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab as First‑Line Treatment for PD-L1-positive NSCLC Accepted for Review by NMPA
2026-05-08T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
 < Previous page    Next page >

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.